Summary
This paper discusses the effects of stimulating melanopsin-containing retinal ganglion cells (mRGCs) on Alzheimer’s and Parkinson’s disease, focusing on the role of bright light therapy (BLT) in potentially improving symptoms and quality of life for patients with these diseases.
Categories
Alzheimer's disease: The paper discusses the prevalence of sleep problems in Alzheimer's disease patients and explores the potential of bright light therapy in improving these issues.
Sleep and insomnia: The paper discusses the common sleep problems seen in patients with Alzheimer's and Parkinson's disease, and how these may be improved through bright light therapy.
Cognitive function and memory: The paper discusses the cognitive decline seen in Alzheimer's disease and how sleep problems may contribute to this, potentially being improved through bright light therapy.
Aging: The paper discusses Alzheimer's and Parkinson's disease, both of which are more prevalent in the elderly, and the potential for bright light therapy to improve symptoms.
Phototherapy: The paper discusses the use of bright light therapy in stimulating mRGCs and potentially improving symptoms in Alzheimer's and Parkinson's disease patients.
Author(s)
C Klaver
Publication Year
2018
Related Publications
Alzheimer's disease
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Phospholipase C families: Common themes and versatility in physiology and pathology
- Neurogenesis and specification of retinal ganglion cells
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
- The impact of light from computer monitors on melatonin levels in college students
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency